Axillary nodal involvement by primary tumor features in early breast cancer: an analysis of 2600 patients.
Published on May 1, 2020in Clinical & Translational Oncology2.737
· DOI :10.1007/S12094-019-02188-7
Background Primary tumor characteristics, which are readily available to all clinicians, may aid in selecting the optimal adjuvant therapy for patients with breast cancer (BC). Herein, we investigated the relationship between tumor size, hormone receptor and HER2 status, Ki67 and age with axillary lymph node metastases (ALNM) in early-BC patients.